Aldosterone synthase inhibition in hypertension: an evolving therapeutic strategy

Current Opinion in Cardiology · Published 2026-03-26 · DOI 10.1097/hco.0000000000001291

Authors being retrieved — see the publisher record. https://doi.org/10.1097/hco.0000000000001291

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Sodium reduction and salt substitutes: impact on blood pressure and recurrent stroke · Current Opinion in Cardiology · 2026 · Same journal
• Artificial intelligence for right ventricular assessment: current evidence and future directions · Current Opinion in Cardiology · 2026 · Same journal
• Postoperative atrial fibrillation after cardiac surgery: what is new? · Current Opinion in Cardiology · 2025 · Same journal
• Artificial intelligence for left ventricular strain · Current Opinion in Cardiology · 2026 · Same journal
• Impact of social determinants of health on cardiovascular health · Current Opinion in Cardiology · 2026 · Same journal
• Applications of genetic testing in cardiovascular disease · Current Opinion in Cardiology · 2026 · Same journal
• Current opinion in cardiology, epigenetics of heart failure · Current Opinion in Cardiology · 2026 · Same journal
• Weight loss as the optimal cardiometabolic management strategy for preventing and treating heart failure · Current Opinion in Cardiology · 2026 · Same journal
• Optimizing conduits and intraoperative graft quality in coronary artery bypass graft surgery · Current Opinion in Cardiology · 2026 · Same journal
• Fetal MRI for cardiopulmonary anomalies: what the pediatric cardiologist and surgeon need to know · Current Opinion in Cardiology · 2026 · Same journal